Lite Strategy, Inc. Fair Value Adjustment of Warrants
Lite Strategy, Inc. (LITS) reported Fair Value Adjustment of Warrants of -$37.79 million for the 12-month period ending 2019-06-30, per its 10-K filed 2019-08-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2019-08-28
- Lite Strategy, Inc. fair value adjustment of warrants for fiscal 2019 was -$37.79M.
| Period end | Fair Value Adjustment of Warrants 12 month |
|---|---|
| 2019-06-30 | -$37.79M 10-K · filed 2019-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |